Merck KGaA (OTCMKTS:MKKGY) Short Interest Down 58.6% in December

Merck KGaA (OTCMKTS:MKKGY) was the recipient of a significant decrease in short interest in December. As of December 31st, there was short interest totaling 100,145 shares, a decrease of 58.6% from the December 15th total of 241,637 shares. Based on an average daily trading volume, of 142,816 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 142,816 shares, the days-to-cover ratio is currently 0.7 days.

Merck KGaA Price Performance

OTCMKTS:MKKGY traded up $0.26 during mid-day trading on Thursday, hitting $30.03. 63,131 shares of the stock traded hands, compared to its average volume of 87,163. The business’s 50-day moving average price is $27.89 and its 200 day moving average price is $26.68. The company has a quick ratio of 0.97, a current ratio of 1.49 and a debt-to-equity ratio of 0.36. The company has a market cap of $19.41 billion, a PE ratio of 11.96, a price-to-earnings-growth ratio of 6.10 and a beta of 0.95. Merck KGaA has a 12-month low of $24.32 and a 12-month high of $31.80.

Merck KGaA (OTCMKTS:MKKGY) last announced its quarterly earnings results on Thursday, November 13th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.54 by $0.27. The firm had revenue of $6.17 billion during the quarter, compared to the consensus estimate of $6.08 billion. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. On average, analysts expect that Merck KGaA will post 1.87 EPS for the current fiscal year.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.